Have your own idea? Try our Stock Screener
UPDATED Feb 19, 2025
Discover Global Growth Stocks from around the world. Sorted by forecasted growth, these stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
A003160 | ₩18,530.00 | 14.7% | 115.7% | ₩449.6b | ₩37,000.00 | PS2.6x | E243.8% | 0.5% | Semiconductors | ||
GAB | €0.73 | 26.6% | 4.4% | €44.3m | €1.50 | PB1.4x | E238.0% | n/a | Real Estate Management and Development | ||
688020 | CN¥35.39 | 3.3% | 18.8% | CN¥2.8b | CN¥78.00 | PS8.9x | E237.8% | 0.5% | Tech | ||
DBI | US$5.22 | 0.8% | -43.2% | US$240.1m | US$6.00 | PB0.8x | E234.4% | 3.8% | Retail | ||
TCF | CA$0.045 | -18.2% | -70.0% | CA$7.2m | n/a | PB0.2x | E230.2% | n/a | Energy | ||
STKL | US$7.24 | -1.6% | 24.6% | US$891.3m | US$10.17 | PS1.2x | E227.3% | n/a | Food, Beverage & Tobacco | ||
PHIO | US$1.74 | -4.9% | -74.2% | US$5.8m | US$4.00 | PB1.2x | E227.2% | n/a | Pharmaceuticals & Biotech | ||
RERE | US$2.92 | -7.9% | 165.5% | US$640.9m | US$3.96 | PB1.3x | E226.4% | n/a | Retail | ||
600037 | CN¥7.52 | -3.3% | 7.1% | CN¥10.6b | CN¥7.60 | PS4.4x | E223.8% | 0.4% | Media | ||
BHC | US$6.51 | 2.4% | -24.9% | US$2.3b | US$8.83 | PE-13.5x | E218.2% | n/a | Pharmaceuticals & Biotech | ||
DB | CA$0.065 | -13.3% | -45.8% | CA$40.4m | n/a | PB0.9x | E212.5% | n/a | Pharmaceuticals & Biotech | ||
LION | US$8.59 | 0.5% | -19.3% | US$2.6b | US$10.50 | PE-11.8x | E209.2% | n/a | Media | ||
SBFM | US$2.57 | 4.0% | -97.9% | US$5.0m | US$300.00 | PB0.2x | E208.2% | n/a | Pharmaceuticals & Biotech | ||
TNZ | CA$15.90 | -3.2% | 306.6% | CA$431.4m | CA$16.75 | PE237.1x | E205.6% | n/a | Energy | ||
OPT | UK£1.80 | 4.0% | n/a | UK£159.8m | UK£2.12 | PS1.5x | E204.8% | n/a | Healthcare | ||
SYZ | CA$9.70 | -2.3% | 6.5% | CA$224.5m | CA$13.67 | PS3.4x | E204.7% | 0.4% | Software | ||
688622 | CN¥71.10 | -3.3% | 246.3% | CN¥4.9b | n/a | PS18.7x | E201.5% | 0% | Tech | ||
TRC | US$15.80 | 2.0% | -4.4% | US$427.6m | US$26.25 | PS10.6x | E201.3% | n/a | Real Estate Management and Development | ||
AMBP3 | R$120.84 | -0.2% | 707.2% | R$20.1b | R$69.50 | PS3.3x | E201.2% | 0.1% | Commercial Services | ||
MINEST | SEK 2.36 | -13.1% | -61.5% | SEK 458.1m | n/a | PS17.4x | E199.1% | n/a | Capital Goods | ||
6547 | NT$47.15 | 0.1% | -22.5% | NT$15.4b | NT$102.00 | PS23.9x | E198.9% | n/a | Pharmaceuticals & Biotech | ||
A274090 | ₩14,270.00 | -12.8% | 18.5% | ₩195.3b | n/a | PS2.1x | E197.3% | n/a | Capital Goods | ||
TKNSA | ₺26.94 | -1.4% | -40.3% | ₺5.4b | ₺66.48 | PB2.3x | E196.8% | 0% | Retail | ||
FPAY | US$1.58 | -2.5% | 39.8% | US$35.2m | US$3.25 | PB4.8x | E194.2% | n/a | Diversified Financials |